PUMA BIOTECHNOLOGY, INC. : Precio Acción Bourse | PBYI | US74587V1070 | MarketScreener
Takeda farms out cancer drug alisertib to Puma Biotech -
PumaBiotech (@pumabiotech) / Twitter
Puma Biotech agrees to pay investors $54.2 mln in fraud case | Reuters
Puma Biotechnology Inc
Former Puma Biotech executive gets U.S. prison term for insider trading | Reuters.com
Puma Biotechnology falls more than 20%
Resumen: Puma Biotechnology y Pierre Fabre firman acuerdo de licencia exclusiva para desarrollar y comercializar NERLYNX® (neratinib) en Europa | Business Wire
Puma Biotech Gets $100M Loan to Boost Breast Cancer Drug - Los Angeles Business Journal
El negocio bursátil de PUMA BIOTECHNOLOGY – Observatorio de biopolitica
Puma Biotech Inc. is looking forward to going to the top - Industry Global News24
PharmaShots - Incisive news in 3 shots on Twitter: "Puma Biotechnology Reports Results of Neratinib (PB272) in P-III NALA Trial for 3L HER2-Positive Metastatic Breast Cancer https://t.co/KKTvnp68jJ https://t.co/LR02TGd4oT" / Twitter
Puma Biotechnology Surging
Federal Jury Awards Puma Biotechnology Investors Damages in Securities Class-Action Verdict - Los Angeles Business Journal
Puma Biotech (PBYI) Stock up as Q2 Earnings & Sales Beat
Puma Biotech Strikes Deal to Develop and Market its Breast Cancer Drug in China - Los Angeles Business Journal
Quartal Beschreibend Perlen puma biotech press release Region Kapitalismus Essen
Puma Biotech Rebranding — Alex Maurer Designs
SEC charges former Puma biotech exec with $1.1 million in insider trading
Resumen: Puma Biotechnology y Pierre Fabre modifican el acuerdo de licencia de NERLYNX® para incluir la Gran China | Business Wire
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
ICOMPRE 2 DE CADA CAJA puma biotechnology jobs Y OBTENGA UN 70% DE DESCUENTO!
Puma Biotech (PBYI) Up More Than 95% in 3 Months: Here's Why
Part 2: Alan Auerbach President & CEO Puma Biotech - YouTube
